The power of placebo in pediatric functional gastrointestinal disease.
Benninga
Marc A
MA
Mayer
Emeran A
EA
D015746:Abdominal Pain / Q000517:prevention & control* / Q000523:psychology; D000293:Adolescent; D000639:Amitriptyline / Q000627:therapeutic use*; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D002648:Child; D004415:Dyspepsia / Q000188:drug therapy* / Q000523:psychology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000523:psychology; D015337:Multicenter Studies as Topic; D010147:Pain Measurement; D015990:Placebo Effect; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012720:Severity of Illness Index; D013577:Syndrome; D013997:Time Factors; D016896:Treatment Outcome
D018712:Analgesics, Non-Narcotic; D005765:Gastrointestinal Agents; D000639:Amitriptyline